Skip to main content
Yabao Pharmaceutical Group Co.,Ltd logo

Yabao Pharmaceutical Group Co.,Ltd — Investor Relations & Filings

Ticker · 600351 ISIN · CNE000001CM5 LEI · 65560071PKRS4UHMVU53 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 1,362 across all filing types
Latest filing 2021-05-14 AGM Information
Country CN China
Listing Shanghai Stock Exchange 600351

About Yabao Pharmaceutical Group Co.,Ltd

http://www.yabao.com.cn

Yabao Pharmaceutical Group Co.,Ltd. focuses on the research, development, manufacturing, and commercialization of pharmaceutical products. The company maintains a specialized portfolio across therapeutic areas including pediatrics, cardiovascular health, and endocrinology. Key offerings include traditional Chinese medicines, chemical drugs, and innovative transdermal patches, such as the Dinggui Erqi Patch. The organization operates integrated production bases and research facilities dedicated to advancing drug delivery systems and biotechnological applications. Its business model emphasizes the modernization of traditional therapies alongside the development of conventional pharmaceuticals to address diverse clinical needs.

Recent filings

Filing Released Lang Actions
北京市中勤律师事务所关于亚宝药业集团股份有限公司2020年度股东大会律师见证法律意见书
AGM Information Classification · 95% confidence The document is a legal opinion letter from a law firm regarding the 2020 Annual General Meeting (AGM) of a company. It details the procedures of the AGM, attendance, voting process, and confirms the legality and validity of the meeting and resolutions passed. It does not contain financial statements or results but focuses on the AGM process and legal compliance. This matches the description of AGM Information (AGM-R), which includes presentations and materials shared during the AGM or related legal opinions. The document length is short (2711 characters), but it is not merely an announcement of a report; it is a legal opinion on the AGM itself. Therefore, the correct classification is AGM Information (AGM-R).
2021-05-14 Chinese
亚宝药业集团股份有限公司关于变更2020年年度业绩说明会召开地点和增加参会人员的提示性公告
Regulatory Filings Classification · 95% confidence The document is a short announcement (1242 characters) about changes to the location and participants of a 2020 annual performance explanation meeting (业绩说明会). It specifies the meeting time, format, platform, and participants but does not contain any financial statements or detailed financial data. It is not the actual performance report or earnings release but an update about the meeting arrangements. According to the 'MENU VS MEAL' rule, such a short notice about a meeting is classified as a Regulatory Filing (RNS) rather than a full report or earnings release.
2021-05-13 Chinese
亚宝药业集团股份有限公司关于召开2020年年度业绩说明会的公告
Investor Presentation Classification · 95% confidence The document is an announcement about the scheduling and details of a 2020 annual performance explanation meeting (业绩说明会) to be held on May 20, 2021. It references the 2020 annual report already disclosed on April 24, 2021, but does not contain the report itself or substantive financial data. The document invites investors to participate in an interactive online session to discuss the annual report and related topics. The document length is short (1275 characters) and it primarily serves as a notice for the upcoming meeting rather than the meeting materials or transcript. Therefore, it fits the category of an Investor Presentation announcement or a meeting notice. However, since it is specifically about an annual performance explanation meeting (业绩说明会), which is a form of investor presentation focused on financial results and company strategy, the best classification is Investor Presentation (IP).
2021-05-12 Chinese
亚宝药业集团股份有限公司2020年年度股东大会会议资料
AGM Information Classification · 95% confidence The document is titled as "2020 年年度股东大会会议资料" which translates to "2020 Annual General Meeting (AGM) materials". It contains detailed agenda items for the AGM, including the presentation and review of the 2020 Annual Report, Board of Directors' work report, Supervisory Board report, Independent Directors' report, and the 2020 financial statements. The document includes meeting procedures, voting instructions, and detailed reports that are typically shared during an AGM. The length of the document (15,000 characters) and the content indicate it is the actual meeting materials, not just an announcement or summary. Therefore, it fits the category of AGM Information (AGM-R).
2021-04-27 Chinese
亚宝药业集团股份有限公司关于全资子公司取得药品注册证书的公告
Regulatory Filings Classification · 95% confidence The document is a public announcement by 亚宝药业集团股份有限公司 regarding its wholly-owned subsidiary obtaining a drug registration certificate from the National Medical Products Administration. It details the drug's registration information, approval, and related background. The document is short (1358 characters) and serves as an official announcement of a regulatory approval event rather than a financial report or detailed management discussion. It does not contain financial statements, earnings data, or management analysis. It is not a report publication announcement since it does not mention any report being attached or published. The content fits best under Regulatory Filings (RNS) as a general regulatory announcement about a significant company event that does not fit other specific categories.
2021-04-26 Chinese
亚宝药业集团股份有限公司关于参与投资上海来石投资管理合伙企业（有限合伙）的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement by 亚宝药业集团股份有限公司 regarding its investment in a limited partnership called 上海来石投资管理合伙企业（有限合伙）. It details the investment amount, the partners involved, the partnership agreement terms, and the potential risks. The document is a formal disclosure of a capital investment transaction, not a financial report, earnings release, or management discussion. It does not contain financial statements or quarterly/yearly results but focuses on the company's financing activity and investment update. Therefore, it fits best under the category of Capital/Financing Update (CAP). The document length and detail support this classification with high confidence.
2021-04-26 Chinese

Browse filings by year

25 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.